Boston Scientific stock jumped Wednesday after the medtech giant easily beat Wall Street's fourth-quarter expectations and its own guidance.

Minnesota system treating atrial fibrillation helped sustain Boston Scientific’s streak of bullish results as the company ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

Boston Scientific said its fourth-quarter net income rose 12% amid robust demand for its stents, catheters and other cardiology devices. The Marlborough, Mass., medical-device maker posted ...

Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...

The latest round of federal CHIPS Act awards includes $105 million for Analog Devices to upgrade its factories in the suburbs around Portland and Boston, the Commerce Department announced early ...

Mahoney said that, with Farapulse, Boston Scientific “disrupted and transformed a hot, large market” in electrophysiology. With Watchman FLX, a left atrial appendage closure (LAAC) device ...

BSX develops, manufactures, and markets medical devices. The company primarily ... But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp ...

JetBlue is adding four new domestic and three international destinations to its schedule for summer flights departing from Boston Logan International Airport.The airline boasts that the seasonal ...

Hologic Inc. has received a warning letter from the Food and Drug Administration regarding its BioZorb product line, even though the company recalled the devices last year. Hologic Inc. has ...

TOKYO -- A disreputable scientific journal used generative AI to create bogus papers, using the names of three Japanese researchers without permission in what is thought to be an instance of ...